May 31, 2024 — June 4, 2024 Chicago, IL

Booth #13059
Industry Expert Theater #2
Evening Reception
Demo our Newest AI & Technology

ASCO® Annual Meeting 2024

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to share our latest scientific and clinical research findings along with new AI-enabled technology during the 2024 ASCO® Annual Meeting.

Schedule a meeting with us

Evening Reception at the Tempus Office

Sunday, June 2nd, 6:00–8:00pm CT

Join us at Tempus Headquarters for lab tours and interactive demos while conversing with peers over food and refreshments. RSVP is required.

RSVP here

Tempus AI & Technology

Experience live demos of our newest technologies for providers, biopharma, and research partners.

Stop by our booth to discover how we are leveraging AI and technology to advance precision oncology.

Tempus One: Interact with our AI-enabled clinical assistant that simplifies access to patient insights. Just ask a question and receive real-time, data-driven answers to inform treatment decisions.

Tempus Next: Discover how we identify patients who may have deviated from their care plans and learn how this technology helps providers close gaps in care, ensuring timely and appropriate interventions.

Tempus Now: See firsthand how our suite of applications integrates seamlessly within EHRs, enabling providers to leverage Tempus technology effortlessly — from test ordering to obtaining results and insights.

Tempus Lens:Quickly find, access, and analyze raw multimodal de-identified data records and uncover critical insights to accelerate research and innovation.

Don't miss the opportunity to see how Tempus is offering one platform for precision oncology by harnessing AI to drive innovation, improve inefficiencies and streamline workflows.

Industry Expert Theater Session
June 1, 2024
live session
3:00–4:00pm CT

Theater #2, Exhibit Hall A
Kate Sasser, PhD, Chief Scientific Officer (Tempus); Ezra Cohen, MD, Chief Medical Officer of Oncology (Tempus); Halla Nimeiri, MD, Chief Development Officer (Tempus)

Transforming Precision Medicine: AI and Molecular Insights Intersect Across the Cancer Care Continuum

Discover the rapid evolution of precision oncology with our cutting-edge AI technology and expanded molecular portfolio, now including MRD and monitoring, to enhance the delivery of comprehensive insights to providers and biopharma professionals.

*Not an official event of the 2024 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation. Not CME-accredited.

Schedule a meeting with us

We'll be in touch shortly.